BPG is committed to discovery and dissemination of knowledge
            
            
                
                
                    
    Articles Published Processes
    
        7/12/2023 7:57:45 AM | Browse: 265 | Download: 1042
    
    
        
        
    
        | 
                
                    |  | Received |  | 2023-04-27 16:01 | 
    
        | 
                
                    |  | Peer-Review Started |  | 2023-04-27 16:04 | 
    
        | 
                
                    |  | To Make the First Decision |  |  | 
    
        | 
                
                    |  | Return for Revision |  | 2023-05-08 03:32 | 
    
        | 
                
                    |  | Revised |  | 2023-05-19 12:40 | 
    
        | 
                
                    |  | Second Decision |  | 2023-06-26 02:56 | 
    
        | 
                
                    |  | Accepted by Journal Editor-in-Chief |  |  | 
    
        | 
                
                    |  | Accepted by Executive Editor-in-Chief |  | 2023-06-26 07:17 | 
    
        | 
                
                    |  | Articles in Press |  | 2023-06-26 07:17 | 
    
        | 
                
                    |  | Publication Fee Transferred |  |  | 
    
        | 
                
                    |  | Edit the Manuscript by Language Editor |  |  | 
    
        | 
                
                    |  | Typeset the Manuscript |  | 2023-07-05 02:01 | 
            
                | 
                        
                            |  | Publish the Manuscript Online |  | 2023-07-12 07:57 | 
        
        
            
                | ISSN | 2307-8960 (online) | 
            
                | Open Access | This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ | 
            
                | Copyright | © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. | 
                    
                        | Article Reprints | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247 | 
            
            
                | Permissions | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207 | 
            
            
                | Publisher | Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | 
            
                | Website | http://www.wjgnet.com | 
        
    
        | Category | Genetics & Heredity | 
    
        | Manuscript Type | Case Report | 
    
        | Article Title | Antithrombin III deficiency in a patient with recurrent venous thromboembolism: A case report | 
    
        | Manuscript Source | Unsolicited Manuscript | 
    
        | All Author List | Jia-Qing Luo, Shuai-Shuai Mao, Jin-Yi Chen, Xue-Ying Ke, Yue-Feng Zhu, Wei Huang, Hai-Ming Sun and Zhen-Jie Liu | 
            
                | ORCID |  | 
    
        | Funding Agency and Grant Number | 
                        
                            
                                | Funding Agency | Grant Number |  
                                        | the National Natural Science Foundation of China | 81670433 and 81970398 |  
                                        | the Project of Zhejiang Medical Young Talents (2017) |  |  
                                        | Zhejiang Medical and Health Science and Technology Project | 2020RC014 |  
                                        | the Natural Science Foundation of Zhejiang Province | LR22H020002 |  | 
    
        | Corresponding Author | Hai-Ming Sun, MD, Chief Physician, Department of Vascular Surgery, Changxing People's Hospital, No. 66 Taihu Middle Road, Changxing 313100, Zhejiang Province, China. sun76543212023@163.com | 
    
        | Key Words | Case report; Anticoagulant therapy; Single nucleotide variant; SERPINC1; Venous thrombosis; Antithrombin | 
    
        | Core Tip | Hereditary thrombophilia can be attributed to mutations in genes such as PROS, PROC, SERPINC1, and F5. Compared to mutations in other genes, mutations of SERPINC1 consistently lead to a more pronounced thrombophilia. Patients with this type of mutation are often advised to take warfarin as a therapeutic measure. However, evidence on the efficacy of direct oral anticoagulants is inadequate. Following identification of the SERPINC1 mutation, our patient was advised to take Rivaroxaban for 5 years to prevent the possibility of thrombus recurrence. This report may supply proof of the efficacy of direct oral anticoagulants in individuals suffering from hereditary thrombophilia. | 
            
                | Publish Date | 2023-07-12 07:57 | 
    
        | Citation | Luo JQ, Mao SS, Chen JY, Ke XY, Zhu YF, Huang W, Sun HM, Liu ZJ. Antithrombin III deficiency in a patient with recurrent venous thromboembolism: A case report. World J Clin Cases 2023; 11(20): 4956-4960 | 
            
                | URL | https://www.wjgnet.com/2307-8960/full/v11/i20/4956.htm | 
            
                | DOI | https://dx.doi.org/10.12998/wjcc.v11.i20.4956 | 
    
    
        
                
        
     
 
                 
             
         
        
    
        
        
            © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
            California Corporate Number: 3537345